Completed PHASE3 INTERVENTIONAL 3-arm NCT00730366

New Approaches to Improve Coverage and Compliance of Antimalarial Treatment for Pregnant Women in Rural Africa

New Approaches to Improve Coverage and Compliance of Antimalarial Treatment for Pregnant Women in Rural Africa.

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Interventions Chloroquine sulfadoxine-pyrimethamine

Updated 5 times since 2017 Last updated: Sep 12, 2010 Started: Mar 31, 2004 Primary completion: Oct 31, 2006 Completion: Dec 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Malaria in Pregnancy, this trial is completed. The trial is conducted by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) and has accumulated 5 data snapshots since 2004. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Mar 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Institute of Tropical Medicine, Belgium
Liverpool School of Tropical Medicine
National Laboratory of Public Health,Burkina Faso
University of Ouagadougou, Burkina Faso

Data source: Institute of Tropical Medicine, Belgium

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boromo, Burkina Faso